Found 5 matching trials
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
PHASE1Only enrolling in Canada.
The purpose of this study is to identify the hig...
Location
Arthur J.E. Child Comprehensive Cancer Centre
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
EARLY_PHASE1CLIC-YYC-GPNMB-02 is a Single Patient Study (SPS) developed according to th...
Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma
EARLY_PHASE1A single patient study to determine whether GCAR1 is safe and effective for...
Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma
EARLY_PHASE1CLIC-YYC-GPNMB-01 is a Single Patient Study (SPS) developed according to th...
Location
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre
A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma
EARLY_PHASE1A single patient study to determine whether GCAR1 is safe and effective for...
Status
Active Not Recruiting
Location
University of Calgary